Member Info for Rajbury

NTL - no-one can (or should) advise you, as we do not know your financial situation.
I'd be tempted to take some profit, though.

licenses

Could be the same buyer trading with three different MMs. Looks like someone's building a position.

That's not a code - just a single-share trade. See them all the time (e.g.look at ARB, NCYT, LOOP recent trades)

SkyM. I use HL, not had the problem you're describing.
Definitely worth a complaint to them, especially if you can demonstrate losses. You may get some compensation.

There was a huge argument over on Avct BB earlier on subject of tenterhooks (someone incorrectly said TENDERhooks).
Looks like it could happen here...

That article is dated Mar 2012!!

What brilliant news....wishing you and her all the best

...at 16.30 close.

Buying because of the steep fall

Actually very few people selling ; and there are some huge buys going through. MMs need to let this go.

Inevitably, with that number of shares analysed, they are not all going to be winners, otherwise we (and he) would be multi-millionaires. I listen to his daily updates, as it helps me understand how shares behave, and yes, it has pointed me towards some great stocks that have come through for me.

You won't lose, Mlse - today's over-reaction to what was a positive, but somewhat confusing, RNS is typical AIM. This company is sitting on one of the planet's biggest Lithium resources, and already interested parties are courting them. It's going to be all positive news flow from here, and smart peeps are already buying in at this bargain price.

Acquisition completed - "transformational.."

I'm regretting it already....

Results for PDS Biotechnology

Did you read the RNS...?

The RNS says they are 'evaluating offers of funding.."

I don't often say it: "BOOOOM"

This pandemic will not be the last; already, scientists are talking about the next global viral outbreak - probably a variant of SARS or MERS, fuelled by our insatiable appetite for chicken and pork. These viruses have much higher mortality rates. Anti-viral masks will become the norm, and all healthcare providers will want to be fully prepared with the PPE they need. Demand for these masks will not go away.